cobaltous chloride has been researched along with Granulomatous Disease, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, C; Gassmann, M; Kvietikova, I; Maly, FE; Marti, HH; Schuerer-Maly, CC; Wenger, RH | 1 |
1 other study(ies) available for cobaltous chloride and Granulomatous Disease, Chronic
| Article | Year |
|---|---|
Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase.
Topics: B-Lymphocytes; Base Sequence; Biomarkers; Cell Hypoxia; Cell Line, Transformed; Cobalt; Cytochrome b Group; Endothelial Growth Factors; Fructose-Bisphosphate Aldolase; Gene Expression Regulation; Granulomatous Disease, Chronic; Humans; Hydrogen Peroxide; Lymphokines; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Sequence Data; Multienzyme Complexes; NADH, NADPH Oxidoreductases; NADPH Dehydrogenase; NADPH Oxidase 2; NADPH Oxidases; Oxygen; Partial Pressure; Phosphoproteins; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1996 |